Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis

Journal of Neuroimmunology

Volumn 232, Issue 1-2, 2011, Pages 35-40

  Pachner, Andrew R ^a   Li, Libin ^a   Lagunoff, David ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Blood brain barrier; Immunoglobulin; Inflammation; Multiple sclerosis; Plasma cells; Theiler's virus

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CELL STRUCTURE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DEMYELINATION; DISABILITY; FEMALE; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL;

ANIMALS; BLOOD-BRAIN BARRIER; CELL SEPARATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOGLOBULIN G; MICE; MICROSCOPY, CONFOCAL; MULTIPLE SCLEROSIS; PLASMA CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; THEILOVIRUS;

EID: 79952244334     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.09.026     Document Type: Article

References (39)

1. Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N. Engl. J. Med. 2003, 349:139-145.
2. Cash E., Bandeira A., Chirinian S., Brahic M. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus. J. Immunol. 1989, 143:984-988.
3. Cassese G., Lindenau S., de Boer B., Arce S., Hauser A., Riemekasten G., Berek C., Hiepe F., Krenn V., Radbruch A., Manz R.A. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur. J. Immunol. 2001, 31:2726-2732.
4. Cassese G., Arce S., Hauser A.E., Lehnert K., Moewes B., Mostarac M., Muehlinghaus G., Szyska M., Radbruch A., Manz R.A. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 2003, 171:1684-1690.
5. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., Sommer N., Hartung H.P., Hemmer B. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005, 128:1667-1676.
6. Dal Canto M.C., Lipton H.L. Multiple sclerosis. Animal model: Theiler's virus infection in mice. Am. J. Pathol. 1977, 88:497-500.
7. Dorta-Contreras A.J. Reibergrams: essential element in cerebrospinal fluid immunological analysis. Rev. Neurol. 1999, 28:996-998.
8. Fairfax K.A., Kallies A., Nutt S.L., Tarlinton D.M. Plasma cell development: from B-cell subsets to long-term survival niches. Semin. Immunol. 2008, 20:49-58.
9. Guerkov R.E., Targoni O.S., Kreher C.R., Boehm B.O., Herrera M.T., Tary-Lehmann M., Lehmann P.V., Schwander S.K. Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J. Immunol. Meth. 2003, 279:111-121.
10. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
11. Hinson S.R., Roemer S.F., Lucchinetti C.F., Fryer J.P., Kryzer T.J., Chamberlain J.L., Howe C.L., Pittock S.J., Lennon V.A. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J. Exp. Med. 2008, 205:2473-2481.
12. Hoyer B.F., Moser K., Hauser A.E., Peddinghaus A., Voigt C., Eilat D., Radbruch A., Hiepe F., Manz R.A. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J. Exp. Med. 2004, 199:1577-1584.
13. Humby F., Bombardieri M., Manzo A., Kelly S., Blades M.C., Kirkham B., Spencer J., Pitzalis C. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009, 6:e1.
14. Krumbholz M., Theil D., Derfuss T., Rosenwald A., Schrader F., Monoranu C.M., Kalled S.L., Hess D.M., Serafini B., Aloisi F., Wekerle H., Hohlfeld R., Meinl E. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 2005, 201:195-200.
15. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function. Blood 2008, 112:1570-1580.
16. Lefvert A.K., Link H. IgG production within the central nervous system: a critical review of proposed formulae. Ann. Neurol. 1985, 17:13-20.
17. Li L., Narayan K., Pak E., Pachner A.R. Intrathecal antibody production in a mouse model of Lyme neuroborreliosis. J. Neuroimmunol. 2006, 173:56-68.
18. Liebsch R., Kornhuber M.E., Dietl D., Grafin von Einsiedel H., Conrad B. Blood-CSF barrier integrity in multiple sclerosis. Acta Neurol. Scand. 1996, 94:404-410.
19. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47:707-717.
20. Lucchinetti C.F., Mandler R.N., McGavern D., Bruck W., Gleich G., Ransohoff R.M., Trebst C., Weinshenker B., Wingerchuk D., Parisi J.E., Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
21. McGavern D.B., Zoecklein L., Drescher K.M., Rodriguez M. Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp. Neurol. 1999, 158:171-181.
22. Meinl E., Krumbholz M., Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann. Neurol. 2006, 59:880-892.
23. Meinl E., Krumbholz M., Derfuss T., Junker A., Hohlfeld R. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis. J. Neurol. Sci. 2008, 274:42-44.
24. Minges Wols H.A., Ippolito J.A., Yu Z., Palmer J.L., White F.A., Le P.T., Witte P.L. The effects of microenvironment and internal programming on plasma cell survival. Int. Immunol. 2007, 19:837-846.
25. Morrey J.D., Olsen A.L., Siddharthan V., Motter N.E., Wang H., Taro B.S., Chen D., Ruffner D., Hall J.O. Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. J. Gen. Virol. 2008, 89:467-473.
26. Moser K., Tokoyoda K., Radbruch A., MacLennan I., Manz R.A. Stromal niches, plasma cell differentiation and survival. Curr. Opin. Immunol. 2006, 18:265-270.
27. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., Lin L.L., Mantchev G.T., Bram R.J., Noelle R.J. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 2004, 199:91-98.
28. Olsen A.L., Morrey J.D., Smee D.F., Sidwell R.W. Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice. Antivir. Res. 2007, 75:104-112.
29. Pachner A.R., Brady J., Narayan K. Antibody-secreting cells in the central nervous system in an animal model of MS: phenotype, association with disability, and in vitro production of antibody. J. Neuroimmunol. 2007, 190:112-120.
30. Pachner A.R., Li L., Narayan K. Intrathecal antibody production in an animal model of multiple sclerosis. J. Neuroimmunol. 2007, 185:57-63.
31. Prineas J.W., Wright R.G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Investig. 1978, 38:409-421.
32. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dorner T., Hiepe F. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 2006, 6:741-750.
33. Regeniter A., Kuhle J., Mehling M., Moller H., Wurster U., Freidank H., Siede W.H. A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting. Clin. Neurol. Neurosurg. 2009, 111:313-318.
34. Reiber H. Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult. Scler. 1998, 4:99-107.
35. Salomonsson S., Jonsson M.V., Skarstein K., Brokstad K.A., Hjelmstrom P., Wahren-Herlenius M., Jonsson R. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum. 2003, 48:3187-3201.
36. Sze D.M., Toellner K.M., Garcia de Vinuesa C., Taylor D.R., MacLennan I.C. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 2000, 192:813-821.
37. Thompson E.J., Freedman M.S. Cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Adv. Neurol. 2006, 98:147-160.
38. von Budingen H.C., Harrer M.D., Kuenzle S., Meier M., Goebels N. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur. J. Immunol. 2008, 38:2014-2023.
39. Zhou D., Srivastava R., Nessler S., Grummel V., Sommer N., Bruck W., Hartung H.P., Stadelmann C., Hemmer B. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:19057-19062.